Global IBS Treatment Market Size, Status and Forecast 2024-2031

Report ID: 954987 | Published Date: Jan 2025 | No. of Page: 126 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global IBS Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 IBS-D
        1.2.3 IBS-C
        1.2.4 IBS-M
    1.3 Market by Application
        1.3.1 Global IBS Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Laboratories
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global IBS Treatment Market Perspective (2016-2027)
    2.2 IBS Treatment Growth Trends by Regions
        2.2.1 IBS Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 IBS Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 IBS Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 IBS Treatment Industry Dynamic
        2.3.1 IBS Treatment Market Trends
        2.3.2 IBS Treatment Market Drivers
        2.3.3 IBS Treatment Market Challenges
        2.3.4 IBS Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top IBS Treatment Players by Revenue
        3.1.1 Global Top IBS Treatment Players by Revenue (2016-2021)
        3.1.2 Global IBS Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global IBS Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by IBS Treatment Revenue
    3.4 Global IBS Treatment Market Concentration Ratio
        3.4.1 Global IBS Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by IBS Treatment Revenue in 2020
    3.5 IBS Treatment Key Players Head office and Area Served
    3.6 Key Players IBS Treatment Product Solution and Service
    3.7 Date of Enter into IBS Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 IBS Treatment Breakdown Data by Type
    4.1 Global IBS Treatment Historic Market Size by Type (2016-2021)
    4.2 Global IBS Treatment Forecasted Market Size by Type (2022-2027)

5 IBS Treatment Breakdown Data by Application
    5.1 Global IBS Treatment Historic Market Size by Application (2016-2021)
    5.2 Global IBS Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America IBS Treatment Market Size (2016-2027)
    6.2 North America IBS Treatment Market Size by Type
        6.2.1 North America IBS Treatment Market Size by Type (2016-2021)
        6.2.2 North America IBS Treatment Market Size by Type (2022-2027)
        6.2.3 North America IBS Treatment Market Size by Type (2016-2027)
    6.3 North America IBS Treatment Market Size by Application
        6.3.1 North America IBS Treatment Market Size by Application (2016-2021)
        6.3.2 North America IBS Treatment Market Size by Application (2022-2027)
        6.3.3 North America IBS Treatment Market Size by Application (2016-2027)
    6.4 North America IBS Treatment Market Size by Country
        6.4.1 North America IBS Treatment Market Size by Country (2016-2021)
        6.4.2 North America IBS Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe IBS Treatment Market Size (2016-2027)
    7.2 Europe IBS Treatment Market Size by Type
        7.2.1 Europe IBS Treatment Market Size by Type (2016-2021)
        7.2.2 Europe IBS Treatment Market Size by Type (2022-2027)
        7.2.3 Europe IBS Treatment Market Size by Type (2016-2027)
    7.3 Europe IBS Treatment Market Size by Application
        7.3.1 Europe IBS Treatment Market Size by Application (2016-2021)
        7.3.2 Europe IBS Treatment Market Size by Application (2022-2027)
        7.3.3 Europe IBS Treatment Market Size by Application (2016-2027)
    7.4 Europe IBS Treatment Market Size by Country
        7.4.1 Europe IBS Treatment Market Size by Country (2016-2021)
        7.4.2 Europe IBS Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific IBS Treatment Market Size (2016-2027)
    8.2 Asia-Pacific IBS Treatment Market Size by Type
        8.2.1 Asia-Pacific IBS Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific IBS Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific IBS Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific IBS Treatment Market Size by Application
        8.3.1 Asia-Pacific IBS Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific IBS Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific IBS Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific IBS Treatment Market Size by Region
        8.4.1 Asia-Pacific IBS Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific IBS Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America IBS Treatment Market Size (2016-2027)
    9.2 Latin America IBS Treatment Market Size by Type
        9.2.1 Latin America IBS Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America IBS Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America IBS Treatment Market Size by Type (2016-2027)
    9.3 Latin America IBS Treatment Market Size by Application
        9.3.1 Latin America IBS Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America IBS Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America IBS Treatment Market Size by Application (2016-2027)
    9.4 Latin America IBS Treatment Market Size by Country
        9.4.1 Latin America IBS Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America IBS Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa IBS Treatment Market Size (2016-2027)
    10.2 Middle East & Africa IBS Treatment Market Size by Type
        10.2.1 Middle East & Africa IBS Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa IBS Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa IBS Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa IBS Treatment Market Size by Application
        10.3.1 Middle East & Africa IBS Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa IBS Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa IBS Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa IBS Treatment Market Size by Country
        10.4.1 Middle East & Africa IBS Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa IBS Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Allergan (Ireland)
        11.1.1 Allergan (Ireland) Company Details
        11.1.2 Allergan (Ireland) Business Overview
        11.1.3 Allergan (Ireland) IBS Treatment Introduction
        11.1.4 Allergan (Ireland) Revenue in IBS Treatment Business (2016-2021)
        11.1.5 Allergan (Ireland) Recent Development
    11.2 Sucampo Pharmaceuticals (U.S.)
        11.2.1 Sucampo Pharmaceuticals (U.S.) Company Details
        11.2.2 Sucampo Pharmaceuticals (U.S.) Business Overview
        11.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Introduction
        11.2.4 Sucampo Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021)
        11.2.5 Sucampo Pharmaceuticals (U.S.) Recent Development
    11.3 Ironwood Pharmaceuticals (U.S.)
        11.3.1 Ironwood Pharmaceuticals (U.S.) Company Details
        11.3.2 Ironwood Pharmaceuticals (U.S.) Business Overview
        11.3.3 Ironwood Pharmaceuticals (U.S.) IBS Treatment Introduction
        11.3.4 Ironwood Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021)
        11.3.5 Ironwood Pharmaceuticals (U.S.) Recent Development
    11.4 Astellas Pharma (Japan)
        11.4.1 Astellas Pharma (Japan) Company Details
        11.4.2 Astellas Pharma (Japan) Business Overview
        11.4.3 Astellas Pharma (Japan) IBS Treatment Introduction
        11.4.4 Astellas Pharma (Japan) Revenue in IBS Treatment Business (2016-2021)
        11.4.5 Astellas Pharma (Japan) Recent Development
    11.5 Bausch Health
        11.5.1 Bausch Health Company Details
        11.5.2 Bausch Health Business Overview
        11.5.3 Bausch Health IBS Treatment Introduction
        11.5.4 Bausch Health Revenue in IBS Treatment Business (2016-2021)
        11.5.5 Bausch Health Recent Development
    11.6 Abbott Laboratories (U.S.)
        11.6.1 Abbott Laboratories (U.S.) Company Details
        11.6.2 Abbott Laboratories (U.S.) Business Overview
        11.6.3 Abbott Laboratories (U.S.) IBS Treatment Introduction
        11.6.4 Abbott Laboratories (U.S.) Revenue in IBS Treatment Business (2016-2021)
        11.6.5 Abbott Laboratories (U.S.) Recent Development
    11.7 Synergy Pharmaceuticals (U.S.)
        11.7.1 Synergy Pharmaceuticals (U.S.) Company Details
        11.7.2 Synergy Pharmaceuticals (U.S.) Business Overview
        11.7.3 Synergy Pharmaceuticals (U.S.) IBS Treatment Introduction
        11.7.4 Synergy Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021)
        11.7.5 Synergy Pharmaceuticals (U.S.) Recent Development
    11.8 Ardelyx (U.S.)
        11.8.1 Ardelyx (U.S.) Company Details
        11.8.2 Ardelyx (U.S.) Business Overview
        11.8.3 Ardelyx (U.S.) IBS Treatment Introduction
        11.8.4 Ardelyx (U.S.) Revenue in IBS Treatment Business (2016-2021)
        11.8.5 Ardelyx (U.S.) Recent Development
    11.9 Nestle (Switzerland)
        11.9.1 Nestle (Switzerland) Company Details
        11.9.2 Nestle (Switzerland) Business Overview
        11.9.3 Nestle (Switzerland) IBS Treatment Introduction
        11.9.4 Nestle (Switzerland) Revenue in IBS Treatment Business (2016-2021)
        11.9.5 Nestle (Switzerland) Recent Development
    11.10 Sebela Pharmaceuticals (Ireland)
        11.10.1 Sebela Pharmaceuticals (Ireland) Company Details
        11.10.2 Sebela Pharmaceuticals (Ireland) Business Overview
        11.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Introduction
        11.10.4 Sebela Pharmaceuticals (Ireland) Revenue in IBS Treatment Business (2016-2021)
        11.10.5 Sebela Pharmaceuticals (Ireland) Recent Development
    11.11 Probi (Sweden)
        11.11.1 Probi (Sweden) Company Details
        11.11.2 Probi (Sweden) Business Overview
        11.11.3 Probi (Sweden) IBS Treatment Introduction
        11.11.4 Probi (Sweden) Revenue in IBS Treatment Business (2016-2021)
        11.11.5 Probi (Sweden) Recent Development
    11.12 Alfasigma USA (Italy)
        11.12.1 Alfasigma USA (Italy) Company Details
        11.12.2 Alfasigma USA (Italy) Business Overview
        11.12.3 Alfasigma USA (Italy) IBS Treatment Introduction
        11.12.4 Alfasigma USA (Italy) Revenue in IBS Treatment Business (2016-2021)
        11.12.5 Alfasigma USA (Italy) Recent Development
    11.13 RedHill Biopharma (Israel)
        11.13.1 RedHill Biopharma (Israel) Company Details
        11.13.2 RedHill Biopharma (Israel) Business Overview
        11.13.3 RedHill Biopharma (Israel) IBS Treatment Introduction
        11.13.4 RedHill Biopharma (Israel) Revenue in IBS Treatment Business (2016-2021)
        11.13.5 RedHill Biopharma (Israel) Recent Development
    11.14 AstraZeneca (U.K)
        11.14.1 AstraZeneca (U.K) Company Details
        11.14.2 AstraZeneca (U.K) Business Overview
        11.14.3 AstraZeneca (U.K) IBS Treatment Introduction
        11.14.4 AstraZeneca (U.K) Revenue in IBS Treatment Business (2016-2021)
        11.14.5 AstraZeneca (U.K) Recent Development
    11.15 Ipsen (France)
        11.15.1 Ipsen (France) Company Details
        11.15.2 Ipsen (France) Business Overview
        11.15.3 Ipsen (France) IBS Treatment Introduction
        11.15.4 Ipsen (France) Revenue in IBS Treatment Business (2016-2021)
        11.15.5 Ipsen (France) Recent Development
    11.16 Novartis (Switzerland)
        11.16.1 Novartis (Switzerland) Company Details
        11.16.2 Novartis (Switzerland) Business Overview
        11.16.3 Novartis (Switzerland) IBS Treatment Introduction
        11.16.4 Novartis (Switzerland) Revenue in IBS Treatment Business (2016-2021)
        11.16.5 Novartis (Switzerland) Recent Development
    11.17 Takeda Pharmaceutical Company (Japan)
        11.17.1 Takeda Pharmaceutical Company (Japan) Company Details
        11.17.2 Takeda Pharmaceutical Company (Japan) Business Overview
        11.17.3 Takeda Pharmaceutical Company (Japan) IBS Treatment Introduction
        11.17.4 Takeda Pharmaceutical Company (Japan) Revenue in IBS Treatment Business (2016-2021)
        11.17.5 Takeda Pharmaceutical Company (Japan) Recent Development
    11.18 Synthetic Biologics (U.S.)
        11.18.1 Synthetic Biologics (U.S.) Company Details
        11.18.2 Synthetic Biologics (U.S.) Business Overview
        11.18.3 Synthetic Biologics (U.S.) IBS Treatment Introduction
        11.18.4 Synthetic Biologics (U.S.) Revenue in IBS Treatment Business (2016-2021)
        11.18.5 Synthetic Biologics (U.S.) Recent Development
    11.18 Protagonist Therapeutics (U.S.)
        .1 Protagonist Therapeutics (U.S.) Company Details
        .2 Protagonist Therapeutics (U.S.) Business Overview
        .3 Protagonist Therapeutics (U.S.) IBS Treatment Introduction
        .4 Protagonist Therapeutics (U.S.) Revenue in IBS Treatment Business (2016-2021)
        .5 Protagonist Therapeutics (U.S.) Recent Development
    11.20 Pfizer (U.S.)
        11.20.1 Pfizer (U.S.) Company Details
        11.20.2 Pfizer (U.S.) Business Overview
        11.20.3 Pfizer (U.S.) IBS Treatment Introduction
        11.20.4 Pfizer (U.S.) Revenue in IBS Treatment Business (2016-2021)
        11.20.5 Pfizer (U.S.) Recent Development
    11.21 Lexicon Pharmaceuticals (U.S.)
        11.21.1 Lexicon Pharmaceuticals (U.S.) Company Details
        11.21.2 Lexicon Pharmaceuticals (U.S.) Business Overview
        11.21.3 Lexicon Pharmaceuticals (U.S.) IBS Treatment Introduction
        11.21.4 Lexicon Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021)
        11.21.5 Lexicon Pharmaceuticals (U.S.) Recent Development
    11.22 Innovate Biopharmaceuticals (U.S.)
        11.22.1 Innovate Biopharmaceuticals (U.S.) Company Details
        11.22.2 Innovate Biopharmaceuticals (U.S.) Business Overview
        11.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Introduction
        11.22.4 Innovate Biopharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021)
        11.22.5 Innovate Biopharmaceuticals (U.S.) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global IBS Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of IBS-D
    Table 3. Key Players of IBS-C
    Table 4. Key Players of IBS-M
    Table 5. Global IBS Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global IBS Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global IBS Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global IBS Treatment Market Share by Regions (2016-2021)
    Table 9. Global IBS Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global IBS Treatment Market Share by Regions (2022-2027)
    Table 11. IBS Treatment Market Trends
    Table 12. IBS Treatment Market Drivers
    Table 13. IBS Treatment Market Challenges
    Table 14. IBS Treatment Market Restraints
    Table 15. Global IBS Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global IBS Treatment Market Share by Players (2016-2021)
    Table 17. Global Top IBS Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBS Treatment as of 2020)
    Table 18. Ranking of Global Top IBS Treatment Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by IBS Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players IBS Treatment Product Solution and Service
    Table 22. Date of Enter into IBS Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global IBS Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global IBS Treatment Revenue Market Share by Type (2016-2021)
    Table 26. Global IBS Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global IBS Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global IBS Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global IBS Treatment Revenue Market Share by Application (2016-2021)
    Table 30. Global IBS Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global IBS Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America IBS Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America IBS Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America IBS Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America IBS Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America IBS Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America IBS Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe IBS Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe IBS Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe IBS Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe IBS Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe IBS Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe IBS Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific IBS Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific IBS Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific IBS Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific IBS Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific IBS Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific IBS Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America IBS Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America IBS Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America IBS Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America IBS Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America IBS Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America IBS Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa IBS Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa IBS Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa IBS Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa IBS Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa IBS Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa IBS Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Allergan (Ireland) Company Details
    Table 63. Allergan (Ireland) Business Overview
    Table 64. Allergan (Ireland) IBS Treatment Product
    Table 65. Allergan (Ireland) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 66. Allergan (Ireland) Recent Development
    Table 67. Sucampo Pharmaceuticals (U.S.) Company Details
    Table 68. Sucampo Pharmaceuticals (U.S.) Business Overview
    Table 69. Sucampo Pharmaceuticals (U.S.) IBS Treatment Product
    Table 70. Sucampo Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 71. Sucampo Pharmaceuticals (U.S.) Recent Development
    Table 72. Ironwood Pharmaceuticals (U.S.) Company Details
    Table 73. Ironwood Pharmaceuticals (U.S.) Business Overview
    Table 74. Ironwood Pharmaceuticals (U.S.) IBS Treatment Product
    Table 75. Ironwood Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 76. Ironwood Pharmaceuticals (U.S.) Recent Development
    Table 77. Astellas Pharma (Japan) Company Details
    Table 78. Astellas Pharma (Japan) Business Overview
    Table 79. Astellas Pharma (Japan) IBS Treatment Product
    Table 80. Astellas Pharma (Japan) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 81. Astellas Pharma (Japan) Recent Development
    Table 82. Bausch Health Company Details
    Table 83. Bausch Health Business Overview
    Table 84. Bausch Health IBS Treatment Product
    Table 85. Bausch Health Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 86. Bausch Health Recent Development
    Table 87. Abbott Laboratories (U.S.) Company Details
    Table 88. Abbott Laboratories (U.S.) Business Overview
    Table 89. Abbott Laboratories (U.S.) IBS Treatment Product
    Table 90. Abbott Laboratories (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 91. Abbott Laboratories (U.S.) Recent Development
    Table 92. Synergy Pharmaceuticals (U.S.) Company Details
    Table 93. Synergy Pharmaceuticals (U.S.) Business Overview
    Table 94. Synergy Pharmaceuticals (U.S.) IBS Treatment Product
    Table 95. Synergy Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 96. Synergy Pharmaceuticals (U.S.) Recent Development
    Table 97. Ardelyx (U.S.) Company Details
    Table 98. Ardelyx (U.S.) Business Overview
    Table 99. Ardelyx (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 100. Ardelyx (U.S.) Recent Development
    Table 101. Nestle (Switzerland) Company Details
    Table 102. Nestle (Switzerland) Business Overview
    Table 103. Nestle (Switzerland) IBS Treatment Product
    Table 104. Nestle (Switzerland) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 105. Nestle (Switzerland) Recent Development
    Table 106. Sebela Pharmaceuticals (Ireland) Company Details
    Table 107. Sebela Pharmaceuticals (Ireland) Business Overview
    Table 108. Sebela Pharmaceuticals (Ireland) IBS Treatment Product
    Table 109. Sebela Pharmaceuticals (Ireland) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 110. Sebela Pharmaceuticals (Ireland) Recent Development
    Table 111. Probi (Sweden) Company Details
    Table 112. Probi (Sweden) Business Overview
    Table 113. Probi (Sweden) IBS Treatment Product
    Table 114. Probi (Sweden) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 115. Probi (Sweden) Recent Development
    Table 116. Alfasigma USA (Italy) Company Details
    Table 117. Alfasigma USA (Italy) Business Overview
    Table 118. Alfasigma USA (Italy) IBS Treatment Product
    Table 119. Alfasigma USA (Italy) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 120. Alfasigma USA (Italy) Recent Development
    Table 121. RedHill Biopharma (Israel) Company Details
    Table 122. RedHill Biopharma (Israel) Business Overview
    Table 123. RedHill Biopharma (Israel) IBS Treatment Product
    Table 124. RedHill Biopharma (Israel) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 125. RedHill Biopharma (Israel) Recent Development
    Table 126. AstraZeneca (U.K) Company Details
    Table 127. AstraZeneca (U.K) Business Overview
    Table 128. AstraZeneca (U.K) IBS Treatment Product
    Table 129. AstraZeneca (U.K) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 130. AstraZeneca (U.K) Recent Development
    Table 131. Ipsen (France) Company Details
    Table 132. Ipsen (France) Business Overview
    Table 133. Ipsen (France) IBS Treatment Product
    Table 134. Ipsen (France) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 135. Ipsen (France) Recent Development
    Table 136. Novartis (Switzerland) Company Details
    Table 137. Novartis (Switzerland) Business Overview
    Table 138. Novartis (Switzerland) IBS Treatment Product
    Table 139. Novartis (Switzerland) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 140. Novartis (Switzerland) Recent Development
    Table 141. Takeda Pharmaceutical Company (Japan) Company Details
    Table 142. Takeda Pharmaceutical Company (Japan) Business Overview
    Table 143. Takeda Pharmaceutical Company (Japan) IBS Treatment Product
    Table 144. Takeda Pharmaceutical Company (Japan) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 145. Takeda Pharmaceutical Company (Japan) Recent Development
    Table 146. Synthetic Biologics (U.S.) Company Details
    Table 147. Synthetic Biologics (U.S.) Business Overview
    Table 148. Synthetic Biologics (U.S.) IBS Treatment Product
    Table 149. Synthetic Biologics (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 150. Synthetic Biologics (U.S.) Recent Development
    Table 151. Protagonist Therapeutics (U.S.) Company Details
    Table 152. Protagonist Therapeutics (U.S.) Business Overview
    Table 153. Protagonist Therapeutics (U.S.) IBS Treatment Product
    Table 154. Protagonist Therapeutics (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 155. Protagonist Therapeutics (U.S.) Recent Development
    Table 156. Pfizer (U.S.) Company Details
    Table 157. Pfizer (U.S.) Business Overview
    Table 158. Pfizer (U.S.) IBS Treatment Product
    Table 159. Pfizer (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 160. Pfizer (U.S.) Recent Development
    Table 161. Lexicon Pharmaceuticals (U.S.) Company Details
    Table 162. Lexicon Pharmaceuticals (U.S.) Business Overview
    Table 163. Lexicon Pharmaceuticals (U.S.) IBS Treatment Product
    Table 164. Lexicon Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 165. Lexicon Pharmaceuticals (U.S.) Recent Development
    Table 166. Innovate Biopharmaceuticals (U.S.) Company Details
    Table 167. Innovate Biopharmaceuticals (U.S.) Business Overview
    Table 168. Innovate Biopharmaceuticals (U.S.) IBS Treatment Product
    Table 169. Innovate Biopharmaceuticals (U.S.) Revenue in IBS Treatment Business (2016-2021) & (US$ Million)
    Table 170. Innovate Biopharmaceuticals (U.S.) Recent Development
    Table 171. Research Programs/Design for This Report
    Table 172. Key Data Information from Secondary Sources
    Table 173. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global IBS Treatment Market Share by Type: 2020 VS 2027
    Figure 2. IBS-D Features
    Figure 3. IBS-C Features
    Figure 4. IBS-M Features
    Figure 5. Global IBS Treatment Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Research Laboratories Case Studies
    Figure 9. IBS Treatment Report Years Considered
    Figure 10. Global IBS Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global IBS Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global IBS Treatment Market Share by Regions: 2020 VS 2027
    Figure 13. Global IBS Treatment Market Share by Regions (2022-2027)
    Figure 14. Global IBS Treatment Market Share by Players in 2020
    Figure 15. Global Top IBS Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBS Treatment as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by IBS Treatment Revenue in 2020
    Figure 17. Global IBS Treatment Revenue Market Share by Type (2016-2021)
    Figure 18. Global IBS Treatment Revenue Market Share by Type (2022-2027)
    Figure 19. North America IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America IBS Treatment Market Share by Type (2016-2027)
    Figure 21. North America IBS Treatment Market Share by Application (2016-2027)
    Figure 22. North America IBS Treatment Market Share by Country (2016-2027)
    Figure 23. United States IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe IBS Treatment Market Share by Type (2016-2027)
    Figure 27. Europe IBS Treatment Market Share by Application (2016-2027)
    Figure 28. Europe IBS Treatment Market Share by Country (2016-2027)
    Figure 29. Germany IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific IBS Treatment Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific IBS Treatment Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific IBS Treatment Market Share by Region (2016-2027)
    Figure 39. China IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America IBS Treatment Market Share by Type (2016-2027)
    Figure 47. Latin America IBS Treatment Market Share by Application (2016-2027)
    Figure 48. Latin America IBS Treatment Market Share by Country (2016-2027)
    Figure 49. Mexico IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa IBS Treatment Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa IBS Treatment Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa IBS Treatment Market Share by Country (2016-2027)
    Figure 55. Turkey IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE IBS Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Allergan (Ireland) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 59. Sucampo Pharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 60. Ironwood Pharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 61. Astellas Pharma (Japan) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 62. Bausch Health Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 63. Abbott Laboratories (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 64. Synergy Pharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 65. Ardelyx (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 66. Nestle (Switzerland) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 67. Sebela Pharmaceuticals (Ireland) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 68. Probi (Sweden) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 69. Alfasigma USA (Italy) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 70. RedHill Biopharma (Israel) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 71. AstraZeneca (U.K) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 72. Ipsen (France) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 73. Novartis (Switzerland) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 74. Takeda Pharmaceutical Company (Japan) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 75. Synthetic Biologics (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 76. Protagonist Therapeutics (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 77. Pfizer (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 78. Lexicon Pharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 79. Innovate Biopharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2016-2021)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan (Ireland)
Sucampo Pharmaceuticals (U.S.)
Ironwood Pharmaceuticals (U.S.)
Astellas Pharma (Japan)
Bausch Health
Abbott Laboratories (U.S.)
Synergy Pharmaceuticals (U.S.)
Ardelyx (U.S.)
Nestle (Switzerland)
Sebela Pharmaceuticals (Ireland)
Probi (Sweden)
Alfasigma USA (Italy)
RedHill Biopharma (Israel)
AstraZeneca (U.K)
Ipsen (France)
Novartis (Switzerland)
Takeda Pharmaceutical Company (Japan)
Synthetic Biologics (U.S.)
Protagonist Therapeutics (U.S.)
Pfizer (U.S.)
Lexicon Pharmaceuticals (U.S.)
Innovate Biopharmaceuticals (U.S.)
Frequently Asked Questions
IBS Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
IBS Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
IBS Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Homeopathic Medicine

Homeopathy is a field of alternative medicine, introduced by Samuel Hahnemann in 1976. It works o ... Read More

Hepatitis C Drugs

Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin,  ... Read More